Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.23 +0.28 (+1.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Non-Current Assets (2020 - 2026)

Updated

Cullinan Therapeutics (CGEM) reported Non-Current Assets of $21.81 million for Q2 2026, down 91.1% from $244.42 million a year earlier and down 47.5% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Cullinan Therapeutics posted Non-Current Assets of $61.62 million, down 70.3% from FY2024.

  • Non-Current Assets has a five-year compound annual growth rate of 90.9% (FY2020 to FY2025).
  • By year, Non-Current Assets came in at $207.16 million in FY2024, $3.99 million in FY2023 (-95.4%), $86.65 million in FY2022 (-38.4%) and $140.62 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q2 2024.
  • Year over year, Non-Current Assets has now declined in each of the last three quarters, with growth averaging 25.3% over the last five quarters.
  • The high point for year-over-year Non-Current Assets in five years was Q1 2022 (growth of 255.7%); the low point was Q1 2024 (a decline of 96.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $41.58 million (Q1 2026), $61.62 million (Q4 2025) and $141.89 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Cullinan Therapeutics 961.97 Mn 961.97 Mn - 21.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.81 Mn
Mar 31, 2026 41.58 Mn
Dec 31, 2025 61.62 Mn
Sep 30, 2025 141.89 Mn
Jun 30, 2025 244.42 Mn
Mar 31, 2025 261.91 Mn
Dec 31, 2024 207.16 Mn
Sep 30, 2024 61.22 Mn
Jun 30, 2024 3.42 Mn
Mar 31, 2024 3.71 Mn
Dec 31, 2023 3.99 Mn
Sep 30, 2023 18.00 Mn
Jun 30, 2023 23.75 Mn
Mar 31, 2023 115.96 Mn
Dec 31, 2022 86.65 Mn
Sep 30, 2022 35.16 Mn
Jun 30, 2022 44.41 Mn
Mar 31, 2022 115.15 Mn
Dec 31, 2021 140.62 Mn
Sep 30, 2021 124.57 Mn
API Access

Cullinan Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=CGEM&period=max&api_key=YOUR_API_KEY